Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
John Milligan
Pharma
Gilead's ex-CEO racked up $26M in pay, severance for 2018
Gilead CEO John Milligan racked up $26M in 2018 pay, on paper at least, while incoming chief Daniel O'Day is in line for a cool $30M this year.
Tracy Staton
Mar 18, 2019 12:27pm
Gilead's HIV portfolio soars, but can it make up for HCV losses?
Oct 26, 2018 10:53am
Celgene veteran Fouse top pick for Gilead CEO: analyst
Jul 31, 2018 11:00am
Gilead's top execs Milligan and Martin stepping down
Jul 25, 2018 5:01pm
Growth-stymied Gilead promotes dealmaker to top strategy post
Jun 5, 2018 12:21pm
With hep C still under fire, Gilead's bottoming out
May 2, 2018 11:41am
